Search research articles

Related Concept Videos

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Lineage Commitment

Lineage Commitment

Commitment is the process whereby stem cells:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Overcoming five main challenges to targeting hematologic malignancies.

Cytotherapy·2026

Same author

Ex Vivo Expansion of Melanoma Tumor-Infiltrating Lymphocytes Leads to a Dominant Exhausted T-cell Population with a Lack of Memory Markers.

Cancer immunology research·2026

Same author

Clinical Evidence of Mesenchymal Stromal Cells for Cerebral Palsy: Scoping Review with Meta-Analysis of Efficacy in Gross Motor Outcomes.

Cells·2025

Same author

Core Needle Biopsies as an Alternative Source for Ex Vivo Expanded TIL for Adoptive Cell Therapy in Triple-Negative Breast Cancer.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2023

Same author

Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery.

Frontiers in immunology·2023

Same author

Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure.

Molecular cancer·2022

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 20, 2026

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

Published on: May 19, 2023

Lnk deficiency partially mitigates hematopoietic stem cell aging.

Alexey Bersenev¹, Krasimira Rozenova, Joanna Balcerek

¹Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA 19104-4318, USA.

|July 21, 2012

Summary

Loss of the Lnk adaptor protein in hematopoietic stem cells (HSCs) mitigates age-related declines in HSC function and self-renewal. This suggests Lnk plays a key role in HSC aging.

More Related Videos

Stromal Cell Isolation From Hematopoietic Organs

Stromal Cell Isolation From Hematopoietic Organs

Published on: January 26, 2024

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Related Experiment Videos

Last Updated: May 20, 2026

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

Published on: May 19, 2023

Stromal Cell Isolation From Hematopoietic Organs

Stromal Cell Isolation From Hematopoietic Organs

Published on: January 26, 2024

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Area of Science:

Hematology
Stem Cell Biology
Aging Research

Background:

Aging increases hematopoietic stem cell (HSC) numbers but decreases their repopulation potential.
Aged HSCs show a myeloid-biased lineage differentiation, impairing lymphoid potential.
The adaptor protein Lnk negatively regulates HSC homeostasis.

Purpose of the Study:

To investigate the role of Lnk in age-related HSC alterations.
To determine if Lnk deficiency impacts HSC self-renewal and lineage bias during aging.

Main Methods:

Comparative analysis of wild-type and Lnk-deficient HSCs from aged mice.
Serial transplantation experiments to assess HSC self-renewal capacity.
Transcriptome analysis to identify altered gene expression patterns and signaling pathways.

Main Results:

Lnk deficiency prevented the age-related increase in HSC numbers.
Aged Lnk-null HSCs exhibited enhanced self-renewal and reduced exhaustion compared to wild-type.
Lnk deficiency ameliorated the age-associated myeloid-lymphoid lineage bias.
Transcriptome analysis revealed altered signaling pathways in Lnk-null HSCs related to self-renewal and aging.

Conclusions:

Loss of Lnk partially rescues age-related functional decline in hematopoietic stem cells.
Lnk is a critical regulator of HSC aging, influencing self-renewal, exhaustion, and lineage potential.